|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 3.420 USD | +1.79% |
|
+7.21% | -44.39% |
| 09-09 | UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating | MT |
| 09-01 | Myriad Genetics Shares Fall After Piper Sandler Downgrade | MT |
Chart calendar Myriad Genetics, Inc.
Upcoming events on Myriad Genetics, Inc.
No events available
Past events on Myriad Genetics, Inc.
| 2026-07-30 | Earnings release - Q2 2026 | |
| 2026-07-30 | Earnings presentation | 16:30 |
| 2026-06-04 | Annual General Meeting | 10:00 |
| 2026-06-04 | Présentation aux Actionnaires / Analystes | 10:00 |
| 2026-05-05 | Earnings release - Q1 2026 | |
| 2026-05-05 | Earnings presentation | 16:30 |
| 2026-02-23 | Earnings presentation | 16:30 |
| 2026-02-23 | Earnings release - Q4 2025 | |
| 2025-11-03 | Earnings presentation | 16:30 |
| 2025-11-03 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 753 751 0.27% | 838 837 0.03% | 825 823 0.22% | 778 | 821 | 870 |
|
EBITDA Million USD | Released Forecast Spread | -6,30 -12,8 50.6% | 40,4 37,0 9.14% | 38,9 30,7 26.56% | -56,0 | -39,2 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -25,5 -29,7 14.13% | 21,8 19,7 10.84% | 15,1 7,34 105.86% | -76,0 | -59,4 | -44,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -262 -263 0.17% | -124 -124 0.1% | -395 -407 2.88% | -148 | -110 | -118 |
|
Net income Million USD | Released Forecast Spread | -263 -256 -2.7% | -127 -121 -5.07% | -366 -379 3.41% | -143 | -106 | -118 |
|
EPS USD | Released Forecast Spread | -3,18 -3,13 -1.68% | -1,41 -1,34 -5.38% | -3,95 -4,08 3.07% | -1,59 | -1,25 | -1,21 |
| Announcement Date | 27/02/24 | 24/02/25 | 23/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 211 210 0.12% | 196 201 -2.3% | 213 202 5.34% | 206 205 0.28% | 210 208 1.08% | 200 202 -1.01% | 191 206 -7.44% | 191 | 196 | 204 | 203 | 206 | 210 | 204 | 206 |
|
EBITDA Million USD | Released Forecast Spread | 10,6 7,84 35.19% | -0,10 -1,92 94.78% | 14,5 4,75 205.09% | 10,3 5,57 84.83% | 14,3 6,46 121.52% | -4,50 0,68 -759.02% | -16,9 0,22 -7850.87% | -18,6 | -15,0 | -9,80 | -9,40 | -9,60 | -9,80 | ||
|
EBIT Million USD | Released Forecast Spread | 5,60 3,42 63.56% | -5,50 -5,98 8.07% | 8,60 -0,55 1654.2% | 4,10 0,08 5289.77% | 7,80 0,12 6255.93% | -10,6 -8,20 -29.23% | -21,7 -1,85 -1072.97% | -20,8 | -18,1 | -16,3 | -17,5 | -14,4 | -13,5 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -39,1 -39,3 0.58% | -29,4 -26,3 -11.59% | -331 -21,5 -1438.28% | -26,2 -19,5 -34.42% | -8,90 -20,6 56.83% | -34,1 -22,6 -50.7% | -42,6 -25,1 -69.58% | -34,2 | -30,6 | -26,7 | -26,9 | -26,3 | -23,5 | -29,8 | -28,9 |
|
Net income Million USD | Released Forecast Spread | -42,5 -36,4 -16.91% | -0,10 -26,9 99.63% | -331 -21,9 -1407.54% | -27,4 -19,8 -38.48% | -7,90 -20,8 62.07% | -34,1 -23,7 -44.09% | -43,2 -25,1 -71.97% | -35,9 | -30,1 | -25,6 | -25,9 | -26,9 | -22,3 | -29,8 | -28,9 |
|
EPS USD | Released Forecast Spread | -0,47 -0,40 -18.09% | 0,00 -0,28 - | -3,57 -0,24 -1412.71% | -0,29 -0,21 -36.47% | -0,08 -0,22 63.22% | -0,36 -0,25 -42.11% | -0,46 -0,27 -72.5% | -0,42 | -0,35 | -0,32 | -0,32 | -0,33 | -0,27 | -0,30 | -0,29 |
| Announcement Date | 24/02/25 | 06/05/25 | 05/08/25 | 03/11/25 | 23/02/26 | 05/05/26 | 30/07/26 | - | - | - | - | - | - | - | - |
| 2026-09-14 |  | Extraordinary General Meeting | 02:30 |
| 2026-09-14 | | Extraordinary General Meeting | 02:30 |
| 2026-09-14 | | Extraordinary General Meeting | 02:30 |
| 2026-09-14 | | Extraordinary General Meeting | 02:00 |
| 2026-09-15 | | Earnings presentation | 01:00 |
| 2026-09-15 | | Earnings presentation | 03:30 |
| 2026-09-16 | | Extraordinary General Meeting | 01:30 |
| 2026-09-16 | | Extraordinary General Meeting | 02:00 |
| 2026-09-17 | | Extraordinary General Meeting | 02:00 |
| 2026-09-17 | | Extraordinary General Meeting | 02:00 |
Past sector events for Myriad Genetics, Inc.
| 2026-09-11 | | Extraordinary General Meeting | 02:30 |
| 2026-09-11 | | Earnings presentation | 02:00 |
| 2026-09-10 | | Extraordinary General Meeting | 02:00 |
| 2026-09-10 | | Earnings presentation | 04:00 |
| 2026-09-09 | | Extraordinary General Meeting | 22:00 |
| 2026-09-09 | | Earnings presentation | 23:00 |
| 2026-09-08 | | Earnings presentation | 06:30 |
| 2026-09-06 | | Earnings presentation | 21:00 |
| 2026-09-05 | | Board of Directors Meeting | 02:17 |
| 2026-09-04 | | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MYGN Stock
- Calendar Myriad Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
